When you write stuff like this, it makes me believe you’re just a bitter investor that doesn’t know what their talking about…
It’s not an apples-to-apples scenario. Yes, AHF had a Q1-to-Q2 uptick last year but that was with old product lines and a cost base they clearly couldn’t sustain.
Today’s growth is driven by a premium formula push (with a2 pros guiding) and significant overhead cuts. Those factors change the quality of the rebound: last year’s bump was more of the same, while this year’s improvements will be the start of a new trajectory assuming the higher-margin strategy gains traction.
When you write stuff like this, it makes me believe you’re just...
Add to My Watchlist
What is My Watchlist?
